SNDX peer analysis
Syndax Pharmaceuticals (SNDX) against its competitors: price, today's move, 1-year return and market value side by side.
SNDX and its peers
| Company | Price | Today | 1-year return | Market cap |
|---|---|---|---|---|
| ALXO ALX Oncology | $1.22 | 0.00% | -21.29% | – |
| CTMX CytomX Therapeutics | $2.34 | 2.18% | -29.73% | $509.88M |
| MGNX MacroGenics | $2.40 | 0.84% | 50.47% | $152.88M |
| NRIX Nurix Therapeutics | $25.70 | -4.09% | 101.13% | – |
| NUVB Nuvation Bio | $4.59 | -3.47% | -10.78% | – |
| ORIC Oric | $9.05 | -2.06% | -32.16% | $957.75M |
| RCUS Arcus Biosciences | $17.84 | -1.90% | -11.61% | $2.32B |
| REPL Replimune | $19.49 | 10.68% | 90.89% | $1.67B |
| XNCR Xencor | $29.68 | -0.47% | 110.05% | $2.22B |
| ZYME Zymeworks | $29.00 | 1.38% | 51.70% | $2.02B |
| SNDX Syndax Pharmaceuticals | $12.90 | -5.49% | -3.66% | $1.22B |
- SNDX's peers: ALXO (ALX Oncology), CTMX (CytomX Therapeutics), MGNX (MacroGenics), NRIX (Nurix Therapeutics), NUVB (Nuvation Bio), ORIC (Oric), RCUS (Arcus Biosciences), REPL (Replimune).
Updated 2026-11-02 23:13 UTC